IT1402382B1 - Complessi cooperativi ibridi di acido ialuronico - Google Patents

Complessi cooperativi ibridi di acido ialuronico

Info

Publication number
IT1402382B1
IT1402382B1 ITMI2010A001635A ITMI20101635A IT1402382B1 IT 1402382 B1 IT1402382 B1 IT 1402382B1 IT MI2010A001635 A ITMI2010A001635 A IT MI2010A001635A IT MI20101635 A ITMI20101635 A IT MI20101635A IT 1402382 B1 IT1402382 B1 IT 1402382B1
Authority
IT
Italy
Prior art keywords
hyaluronic acid
complex hyaluronic
cooperative complex
hybrid cooperative
hybrid
Prior art date
Application number
ITMI2010A001635A
Other languages
English (en)
Inventor
Chiara Schiraldi
Agostino Antonella D
Gatta Annalisa La
Rosa Mario De
Original Assignee
Ibsa Inst Biochimique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43528358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1402382(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ibsa Inst Biochimique Sa filed Critical Ibsa Inst Biochimique Sa
Priority to ITMI2010A001635A priority Critical patent/IT1402382B1/it
Priority to CA2810742A priority patent/CA2810742C/en
Priority to ES11769800.1T priority patent/ES2613067T3/es
Priority to HUE11769800A priority patent/HUE031242T2/en
Priority to PCT/EP2011/065633 priority patent/WO2012032151A2/en
Priority to US13/820,838 priority patent/US20130165404A1/en
Priority to PT117698001T priority patent/PT2614090T/pt
Priority to PL11769800T priority patent/PL2614090T3/pl
Priority to EP11769800.1A priority patent/EP2614090B2/en
Priority to LTEP11769800.1T priority patent/LT2614090T/lt
Priority to DK11769800.1T priority patent/DK2614090T3/da
Priority to CN201180043030.5A priority patent/CN103119068B/zh
Publication of ITMI20101635A1 publication Critical patent/ITMI20101635A1/it
Publication of IT1402382B1 publication Critical patent/IT1402382B1/it
Application granted granted Critical
Priority to US14/974,657 priority patent/US10266611B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ITMI2010A001635A 2010-09-09 2010-09-09 Complessi cooperativi ibridi di acido ialuronico IT1402382B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ITMI2010A001635A IT1402382B1 (it) 2010-09-09 2010-09-09 Complessi cooperativi ibridi di acido ialuronico
PT117698001T PT2614090T (pt) 2010-09-09 2011-09-09 Complexos cooperativos híbridos de ácido hialurónico
EP11769800.1A EP2614090B2 (en) 2010-09-09 2011-09-09 Hybrid cooperative complexes of hyaluronic acid
HUE11769800A HUE031242T2 (en) 2010-09-09 2011-09-09 Hyaluronic Acid Hybrid Cooperative Complexes
PCT/EP2011/065633 WO2012032151A2 (en) 2010-09-09 2011-09-09 Hybrid cooperative complexes of hyaluronic acid
US13/820,838 US20130165404A1 (en) 2010-09-09 2011-09-09 Hybrid cooperative complexes of hyaluronic acid
CA2810742A CA2810742C (en) 2010-09-09 2011-09-09 Hybrid cooperative complexes of hyaluronic acid
PL11769800T PL2614090T3 (pl) 2010-09-09 2011-09-09 Hybrydowe kompleksy kooperatywne kwasu hialuronowego
ES11769800.1T ES2613067T3 (es) 2010-09-09 2011-09-09 Complejos híbridos cooperativos de ácido hialurónico
LTEP11769800.1T LT2614090T (lt) 2010-09-09 2011-09-09 Hibridiniai tarpusavyje susieti hialurono rūgšties kompleksai
DK11769800.1T DK2614090T3 (da) 2010-09-09 2011-09-09 Hybride cooperative komplekser af hyaluronsyre
CN201180043030.5A CN103119068B (zh) 2010-09-09 2011-09-09 透明质酸的杂化协同复合物
US14/974,657 US10266611B2 (en) 2010-09-09 2015-12-18 Hybrid cooperative complexes of hyaluronic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A001635A IT1402382B1 (it) 2010-09-09 2010-09-09 Complessi cooperativi ibridi di acido ialuronico

Publications (2)

Publication Number Publication Date
ITMI20101635A1 ITMI20101635A1 (it) 2012-03-10
IT1402382B1 true IT1402382B1 (it) 2013-09-04

Family

ID=43528358

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A001635A IT1402382B1 (it) 2010-09-09 2010-09-09 Complessi cooperativi ibridi di acido ialuronico

Country Status (11)

Country Link
US (2) US20130165404A1 (it)
EP (1) EP2614090B2 (it)
CA (1) CA2810742C (it)
DK (1) DK2614090T3 (it)
ES (1) ES2613067T3 (it)
HU (1) HUE031242T2 (it)
IT (1) IT1402382B1 (it)
LT (1) LT2614090T (it)
PL (1) PL2614090T3 (it)
PT (1) PT2614090T (it)
WO (1) WO2012032151A2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2444145T3 (es) * 2011-11-24 2014-02-24 Quimera Ingeniería Biomédica, S.L. Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina
ITMI20120896A1 (it) * 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
CN104592702B (zh) * 2014-12-26 2017-05-31 四川大学 可自愈合的有机物/无机纳米粒子杂化材料及其制备方法
ITUB20152542A1 (it) * 2015-07-28 2017-01-28 Altergon Sa Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
CN107802597B (zh) * 2017-12-08 2020-07-31 北京诺康达医药科技股份有限公司 一种玻璃酸钠组合物及其制备方法和应用
IT201900006250A1 (it) 2019-04-23 2020-10-23 Fidia Farm Spa Medicazione per il trattamento della cute lesa
IT201800010415A1 (it) * 2018-11-19 2020-05-19 Innate S R L Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
IT201900021693A1 (it) 2019-11-20 2021-05-20 Bmg Pharma S P A Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
IT201900024214A1 (it) 2019-12-17 2021-06-17 Altergon Sa Sostituti del liquido sinoviale
IT201900024208A1 (it) * 2019-12-17 2021-06-17 Altergon Sa Miscele iniettabili di acido ialuronico per uso in dermoestetica
IT202000002641A1 (it) 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202000002866A1 (it) 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
CN113244384A (zh) 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202000029288A1 (it) 2020-12-01 2022-06-01 Altergon Sa Sali di microbiocidi biguanidinici con glicosamminoglicani
CN113512134B (zh) * 2021-07-30 2022-05-20 梅晔生物医药股份有限公司 一种全分子量分布的透明质酸钠及其制备方法和应用
IT202100027047A1 (it) 2021-10-21 2023-04-21 The Wave Innovation Group Srls Composizione eterogenea a fasi stratificate di acido ialuronico e suo uso intrarticolare

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
AU652022B2 (en) † 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5621093A (en) † 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
US20030104601A1 (en) † 1999-04-01 2003-06-05 Deangelis Paul L. Chondroitin synthase gene and methods of making and using same
US6482401B1 (en) † 1998-12-23 2002-11-19 Naturopathic Laboratories International, Inc. Composition for the relief of joint pain and myofascial pain and method of preparing same
US8003782B1 (en) † 1999-02-01 2011-08-23 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
CN1522161A (zh) * 2001-06-29 2004-08-18 �Ȱ�ά����ķ�ɷݹ�˾ 批量高压灭菌方法
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
WO2004091370A2 (en) * 2003-04-10 2004-10-28 The Trustees Of Boston University Method for stimulating angiogenesis and wound healing
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
MX2007005509A (es) † 2004-11-23 2007-07-09 Alcon Inc Composicion y viscoelastica de polimero natural triple.
US20070010481A1 (en) 2005-07-07 2007-01-11 Matrix Biology Institute Solid State Irradiation of Hyaluronan-Based Solid Preparations, Its Derivatives And Mixtures In An Unsaturated Gaseous Atmosphere And Their Use
WO2007030623A2 (en) 2005-09-07 2007-03-15 Amo Regional Holdings Bi-modal hyaluronate solution
PT2026821E (pt) * 2006-05-11 2009-12-09 Robert John Petrella Misturas binárias de ácido hialurónico e uso terapêutico das mesmas
ITMI20061030A1 (it) † 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) † 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
FR2918276B1 (fr) † 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
PT2296670E (pt) * 2008-05-13 2013-03-25 Apharm Srl Utilização oral de glicosaminoglicana e composições
US20100098794A1 (en) * 2008-10-17 2010-04-22 Armand Gerard Topical anti-wrinkle and anti-aging moisturizing cream
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
IT1404145B1 (it) † 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi

Also Published As

Publication number Publication date
PL2614090T3 (pl) 2017-03-31
WO2012032151A2 (en) 2012-03-15
EP2614090B1 (en) 2016-11-02
DK2614090T3 (da) 2017-01-02
ES2613067T3 (es) 2017-05-22
CA2810742C (en) 2018-08-21
US20130165404A1 (en) 2013-06-27
HUE031242T2 (en) 2017-07-28
CN103119068A (zh) 2013-05-22
ITMI20101635A1 (it) 2012-03-10
EP2614090A2 (en) 2013-07-17
LT2614090T (lt) 2017-01-25
US20160102154A1 (en) 2016-04-14
US10266611B2 (en) 2019-04-23
WO2012032151A3 (en) 2012-08-30
CA2810742A1 (en) 2012-03-15
EP2614090B2 (en) 2024-04-24
PT2614090T (pt) 2017-02-08

Similar Documents

Publication Publication Date Title
IT1402382B1 (it) Complessi cooperativi ibridi di acido ialuronico
BR112012019008A2 (pt) soluções estereis de ácido hialurônico
EP2773014A4 (en) BATTERY SYSTEM
EP2717414A4 (en) CHARGING SYSTEM
EP2714874A4 (en) HYBRID NANOSMITTING AGENT
EP2738912A4 (en) ACCUMULATOR SYSTEM
PT2637710T (pt) Formulações à base de ácido hialurónico
DE112011102176T8 (de) Hybridantriebssystem
HK1201568A1 (en) Hydrolysis probes
EP2682409A4 (en) BY AMINOCARBOXYLIC ACID MODIFIED HYALURONIC ACID DERIVATIVE
EP2768108A4 (en) MOUNTED LOADING SYSTEM
SMT201600071B (it) Derivato di acido pirrolidina-3-ilacetico
EP2717417A4 (en) BATTERY SYSTEM
GB2494141B (en) Charging system
AU4831P (en) Sunparavel Mandevilla hybrid
AU5170P (en) Sunpararenga Mandevilla hybrid
AU5109P (en) Nuflordyna Gazania hybrid
AU5371P (en) CorBzr01 Cordyline hybrid
AU4554P (en) WES03 Westringia hybrid
AU4555P (en) WES02 Westringia hybrid
AU5117P (en) Sunsenepiba Senecio hybrid
IL213782A0 (en) Hybrid technology
GB201105988D0 (en) Acid formation
EP2799424A4 (en) 2-FLUORPHENYLPROPIONSÄUREDERIVAT
AU2011308V (en) Agapetite Agapanthus hybrid